Heinrich Emanuel Merck Award goes to Japanese nanotechnology scientist
Merck KGaA, based in Darmstadt, Germany is the sponsor of the Heinrich Emanuel Merck Award for the promotion of analytical chemistry research. The award is named after the company founder and conferred as a mark of distinction on chemists who have contributed to developing groundbreaking new analytical chemistry methods.
This year's Heinrich Emanuel Merck Award for Analytical Chemistry goes to Professor Yoshinobu Baba, 45, a professor of physical chemistry at the University of Tokushima, Japan. His main area of research is new technologies for decoding DNA, protein and sugar chains. Professor Baba received the award for the paper entitled "Nanospheres for DNA separation chips" published in Nature Biotechnology, 2004, 22 (3). The paper describes a novel nanobiotechnology-based method of analysis that enables the high-speed, high-resolution separation of a broad range of DNA fragments. In experimental use, the nanosphere solution separated DNA fragments in up to 15 000 base pairs at high speed and with high resolution using microchip electrophoresis. In addition, the extremely low-viscosity nanosphere solution is easy to handle and can be used for on-the-spot DNA analysis with no need for a special laboratory.
Professor Baba's report demonstrates that nanomaterial from molecular nanotechnology has applications for chip-based DNA separation. Baba's insights open up the prospect of a new area of scientific research combining the strengths of nanotechnology and biotechnology.
The Heinrich Emanuel Merck Award will be presented at a ceremony to be held on September 5, 2004 at the Euroanalysis XIII conference in Salamanca, Spain.
Merck announced that Udit Batra, currently CEO and President of Merck Millipore, has been appointed to lead the combined life science business of Merck Millipore and Sigma-Aldrich once the acquisition of Sigma-Aldrich has been successfully completed.
The planned $ 17 billion transaction rem ... more
Merck successfully placed a U.S. bond via its U.S. subsidiary EMD Finance LLC. The oversubscribed placement is an important element of the financing of the proposed acquisition of the life science company Sigma-Aldrich, which Merck announced in September 2014.
A total of five tranches were ... more
Merck has successfully completed a year of strategically important moves and achieved its objectives.
“We strengthened all three of Merck’s business sectors: Healthcare, Life Science and Performance Materials. With the acquisition of AZ, the offer to acquire Sigma-Aldrich and the alliance w ... more
Discover the world of Merck Millipore’s Inorganic Reagents! With over 350 pages packed with information, our Inorganic Reagents catalog offers you our complete Inorganic Reagents portfolio in one single volume more
Long-term environmental sustainability and continued reduction in the consumption of non-renewable raw materials is increasingly important for laboratories everywhere. This work compares the effect on the environment of an Elix® 3 water pu more
In recent years, the advent of Ultra High Performance Liquid Chromatography (UHPLC) has broadened the scope of laboratory applications, making it possible to attain extremely low detection limits. Certain requirements exist, however, when working wit more
The Lab Solutions business unit of Merck Millipore supplies products for research, analytical and clinical laboratories in a wide variety of industries. We are one of the leading suppliers of laboratory chemicals, lab water equipment and consumables.
For inorganic chemistry, we offer reagen ... more
Merck Schuchardt OHG, a 100% subsidiary of Merck KGaA, Germany, has, for the last 135 years, been one of the leading German producers and suppliers of organic intermediates, fine chemicals, reagents and solvents for laboratories, medium-sized and bulk production. more
Millipore is a life science leader providing cutting edge technologies, tools, and services for bioscience research and biopharmaceutical manufacturing. As a strategic partner, we collaborate with customers to confront the worlds challenging human health issues. From research to development ... more